Healthcare >> CEO Interviews >> January 15, 2016

Interview with the CFO and Director: Lightlake Therapeutics Inc. (OTCMKTS:LLTP)

Pollack, Kevin
Kevin Pollack is Chief Financial Officer and a Director at Lightlake Therapeutics Inc. Mr. Pollack has been an Investment Banker and Securities Attorney at Banc of America Securities LLC and Sidley Austin LLP — formerly Brown & Wood LLP — respectively, and has previous asset management experience at Paragon Capital LP. He is a magna cum laude graduate of the Wharton School of the University of Pennsylvania, and holds J.D. and MBA degrees from Vanderbilt University, where he graduated with Beta Gamma Sigma honors. Currently, Mr. Pollack sits on the boards of directors of MagneGas Corporation and Pressure BioSciences, Inc. He also is President of Short Hills Capital LLC. Profile
TWST: Can you provide a brief overview of the company and talk about the drug that you have recently received FDA approval for?

Mr. Pollack: Lightlake Therapeutics